Literature DB >> 2547352

Oral acyclovir reduces the incidence of recurrent herpes simplex keratitis in rabbits after penetrating keratoplasty.

C F Beyer1, M Q Arens, G A Hill, B T Rose, L R Beyer, D J Schanzlin.   

Abstract

To determine if acyclovir sodium prevents postoperative herpes simplex virus type 1 (HSV-1) recurrences, 21 rabbits harboring latent HSV-1 underwent uniocular autograft penetrating keratoplasty. All operated-on eyes were treated with topical and subconjunctival dexamethasone sodium phosphate. Ten of the 21 rabbits also received oral acyclovir (intravenous acyclovir was given at the time of surgery). Postoperatively, 9 (82%) of 11 operated-on eyes in rabbits not treated with acyclovir had positive HSV-1 ocular cultures. In acyclovir-treated rabbits, however, none of the 10 operated-on eyes had positive ocular cultures. In addition, 9 (82%) of 11 of the operated-on eyes had geographic ulcers develop in the non-acyclovir-treated rabbits, compared with 1 (10%) of 10 in the acyclovir-treated rabbits. Finally, stromal keratitis appeared in 5 (56%) of 9 of the operated-on eyes in non-acyclovir-treated rabbits and 1 (12%) of 8 of the operated-on eyes in acyclovir-treated rabbits. The results of this study indicate that acyclovir significantly lowered the incidence of HSV-1 ocular shedding, geographic ulceration, and stromal keratitis in a rabbit autograft penetrating keratoplasty model.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2547352     DOI: 10.1001/archopht.1989.01070020266036

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  4 in total

1.  Antiviral treatment following penetrating keratoplasty for herpetic keratitis.

Authors:  J F B Goodfellow; S Nabili; M N A Jones; D Q Nguyen; W J Armitage; S D Cook; D M Tole
Journal:  Eye (Lond)       Date:  2011-01-28       Impact factor: 3.775

2.  Systemic acyclovir and penetrating keratoplasty for herpes simplex keratitis.

Authors:  C S Foster; N P Barney
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

3.  Evidence for herpes simplex viral latency in the human cornea.

Authors:  S B Kaye; C Lynas; A Patterson; J M Risk; K McCarthy; C A Hart
Journal:  Br J Ophthalmol       Date:  1991-04       Impact factor: 4.638

Review 4.  Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  A J Wagstaff; D Faulds; K L Goa
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.